entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 00:37:02 - browse：9

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

knowledge

focus

WSS

With psoriasis trial ahead, Alumis raises $259 million

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Fetal cell organoids grown from amniotic fluid, study finds

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Immune cells and nerve overgrowth may explain recurring UTI pain

Streamlined flu vaccines recommended by FDA advisory panel

focus

entertainment

focus

Bright Health sells Medicare Advantage business to Molina

Medicare drug price negotiation hearing pits pharma v Biden admin

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk obesity pill bests Wegovy in early trial

United colonoscopy coverage change 'may cost lives,' doctors say

First medicine developed to treat MASH expected to be approved soon

Guidelines to prevent youth baseball injuries need more muscle

The Readout: Amylyx, Alumis, and Lundbeck drug updates

23andMe had bad news about my health. I wish a person had delivered it

A deep dive into Applied Therapeutics’ data, and questions on Cassava

focus

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Change Healthcare payments predicted restored March 15

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

$1 billion proposal to grow Boston, Massachusetts biotech

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Amylyx ALS drug failure raises questions and concerns

knowledge

focus

hotspot

knowledge